#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Red blood cell abnormality Lymphoma Glycogen storage disease type I Marginal zone lymphoma refractory Rheumatoid arthritis Hypertriglyceridaemia Haemolytic uraemic syndrome Ataxia telangiectasia Barth syndrome Rhabdomyosarcoma Bile acid synthesis disorder Primary hyperoxaluria Bladder cancer Breast angiosarcoma Glomerulonephritis More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranoproliferative – Trials in Disease Haemophagocytic lymphohistiocytosis – Diagnostics Alport’s syndrome – Basic Information Langerhans cell sarcoma Erdheim-Chester disease – Life with Disease Von Willebrand’s disease – Life with Disease Piriformis syndrome – Life with Disease Hepatoblastoma Glomerulonephritis rapidly progressive – Diagnostics Marfan’s syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lurasidone SONLICROMANOL HYDROCHLORIDE Caffeine Paraffin White Soft Ephedrine Hydrochloride Daxdilimab SODIUM TETRACHLOROPALLADATE Trametinib Hydrocortisone Hemisuccinate Edotreotide 10-1074-Ls Copanlisib Dihydrochloride Mexiletine Lorazepam Sotalol Hydrochloride CLESROVIMAB Diclofenac Epolamine Nimorazole Plasma Afatinib More therapies…

    Learn about Your Condition

    Toxic nodular goitre Anal cancer metastatic Biopsy heart Nephrogenic anaemia Insomnia Torticollis Nodular melanoma Hepatoblastoma Tympanic membrane hyperaemia Vaginal cancer Leukoencephalopathy Enteritis Thyroid disorder HER2 positive gastric cancer Premature baby More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Early Clarithromycin Treatment to Prevent Sepsis in Patients with Community-Acquired Pneumonia

    Recruiting

    3 1 1
    Investigated Drugs:
    • Clarithromycin
    Greece

  • Study on Fecal Microbiota Transplantation for Patients with Axial Spondyloarthritis Resistant to Conventional Treatment

    Recruiting

    2 1
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    France

  • Study on Switching from Anti-C5 Antibody Therapy to Iptacopan for Patients with Atypical Hemolytic Uremic Syndrome (aHUS)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Atypical haemolytic uraemic syndrome
    Investigated Drugs:
    • Iptacopan
    France Germany Italy Spain

  • Study on Tinlarebant for Treating Geographic Atrophy in Patients

    Recruiting

    3 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • Tinlarebant
    Czechia France

  • Study on Clostridium Botulinum Neurotoxin Type A for Treating Myalgia and Myofascial Pain in Patients with Temporomandibular Disorders

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Myofascial pain syndrome
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    Sweden

  • Study on Sacituzumab Govitecan for Patients with Advanced Differentiated and Anaplastic Thyroid Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Anaplastic thyroid cancer
    Investigated Drugs:
    • Sacituzumab Govitecan
    Spain
Previous Page
1 … 431 432 433 434 435 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!